marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Clearside Biomedical Financial Statements 2011-2024 | CLSD
Annual Financial Statements Clearside Biomedical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
101 M | 62 M | 93.3 M | 154 M | 137 M | 36 M | 161 M | 95.1 M | - | - | - | - | - |
Shares |
61.8 M | 60.2 M | 58.5 M | 46.5 M | 38.2 M | 30.7 M | 25.3 M | 13.1 M | - | - | - | - | - |
Historical Prices |
1.64 | 1.03 | 1.59 | 3.31 | 2.24 | 1.45 | 6.46 | 7.85 | - | - | - | - | - |
Net Income |
-32.5 M | -32.9 M | 376 K | -18.2 M | -30.8 M | -82.8 M | -59 M | -25.9 M | -17.6 M | -10.2 M | -7.25 M | - | - |
Revenue |
8.23 M | 1.33 M | 29.6 M | 7.89 M | 2.17 M | 30 K | 345 K | 520 K | - | - | - | - | - |
Cost of Revenue |
355 K | 204 K | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-24.8 M | -30.3 M | -627 K | -17.9 M | -30.3 M | -82.9 M | -58.4 M | -25.2 M | -17.3 M | -9.82 M | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-24.8 M | -30.1 M | -449 K | -17.8 M | -30.1 M | -82.8 M | -58.2 M | -25.1 M | -17.2 M | -9.78 M | -7.22 M | - | - |
Operating Expenses |
33.1 M | 31.6 M | 30.2 M | 25.8 M | 32.5 M | 83 M | 58.8 M | 25.7 M | - | - | - | - | - |
General and Administrative Expenses |
11.9 M | 11.8 M | 11.7 M | 10.8 M | 16.8 M | 14.7 M | 9.7 M | 6.26 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Clearside Biomedical
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
74.7 M | 74.7 M | 62.9 M | 62 M | 61.7 M | 61.2 M | 60.6 M | 60.2 M | 60.2 M | 60.1 M | 59.7 M | 59.5 M | 57.7 M | 57 M | 51.9 M | 47 M | 45.2 M | 44.8 M | 44.4 M | 38.4 M | 37.6 M | 34.1 M | 32.1 M | 32 M | 32 M | 26.8 M | 25.4 M | 25.3 M | 25.3 M | 25.3 M | 24.6 M | 20.5 M | 8.24 M | 2.66 M | 2.66 M | 2.65 M | 2.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-7.69 M | -7.59 M | - | -9.27 M | -9.11 M | -9.28 M | - | -7.83 M | -7.81 M | -7.64 M | - | -4.89 M | -6.1 M | -7.35 M | - | -2.43 M | -5.75 M | -2.91 M | -3.1 M | -6.54 M | -5.73 M | -15.4 M | -21.6 M | -23.9 M | -20.7 M | -16.6 M | -16.5 M | -18.3 M | -13.8 M | -10.4 M | -9.69 M | -5.64 M | -5.1 M | -5.45 M | -5.17 M | -3.48 M | -5.33 M | -3.76 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
1.04 M | 90 K | - | 859 K | 1.02 M | 4 K | - | 266 K | 384 K | 347 K | - | 3.07 M | 780 K | 34 K | - | 3.43 M | 354 K | 4.1 M | - | 141 K | 45 K | 45 K | - | - | - | - | - | 155 K | 130 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | 142 K | 213 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-5.93 M | -7.59 M | - | -7.05 M | -7.27 M | -7.6 M | - | -6.72 M | -7.84 M | -7.65 M | - | -4.89 M | -6.1 M | -8.35 M | - | -2.43 M | -5.56 M | -2.84 M | - | -6.37 M | -5.62 M | -15.3 M | - | -24 M | -20.9 M | -16.5 M | - | -18.2 M | -13.6 M | -10.3 M | - | -5.31 M | -5.18 M | -5.36 M | - | -3.37 M | -5.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | -7.59 M | - | -6.6 M | -7.75 M | -7.6 M | - | -4.76 M | -6.01 M | -8.3 M | - | -2.3 M | -5.47 M | -2.79 M | - | -6.21 M | -5.51 M | -15.3 M | - | -23.8 M | -20.8 M | -16.4 M | - | -18.1 M | -13.6 M | -10.2 M | - | -5.26 M | -5.15 M | -5.34 M | - | -3.33 M | -5.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | 7.91 M | 8.29 M | 7.61 M | - | 6.99 M | 8.22 M | 7.99 M | - | 7.96 M | 6.88 M | 8.38 M | - | 5.86 M | 5.91 M | 6.93 M | 4.96 M | 6.51 M | 5.66 M | 15.4 M | 21.7 M | 24 M | 20.9 M | 16.5 M | 16.4 M | 18.3 M | 13.8 M | 10.3 M | 9.36 M | 5.31 M | 5.18 M | 5.86 M | 5.02 M | 3.37 M | 5.17 M | 3.76 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.84 M | 3.08 M | - | 2.64 M | 3.13 M | 3.16 M | - | 2.35 M | 2.79 M | 3.46 M | - | 2.82 M | 2.82 M | 2.89 M | - | 2.37 M | 2.61 M | 3.12 M | - | 3.78 M | 5 M | 4.38 M | - | 3.87 M | 3.56 M | 3.07 M | - | 2.3 M | 2.29 M | 2.67 M | - | 1.63 M | 970 K | 1.27 M | - | 1.06 M | 3.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency